| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Anette Schra. Psychiatric aspects of Parkinson's disease--an update. Journal of neurology. vol 251. issue 7. 2004-10-20. PMID:15258780. |
the latter range from vivid dreams and hallucinations to delusions, manic symptoms, hypersexuality, dopamine dysregulation syndrome and delirium. |
2004-10-20 |
2023-08-12 |
Not clear |
| K Alagiakrishnan, C A Wien. An approach to drug induced delirium in the elderly. Postgraduate medical journal. vol 80. issue 945. 2004-10-14. PMID:15254302. |
it also reviews the mechanisms for this condition, especially the neurotransmitter imbalances involving acetylcholine, dopamine, and gamma aminobutyric acid and discusses the age related changes that may contribute to altered pharmacological effects which have a role in delirium. |
2004-10-14 |
2023-08-12 |
Not clear |
| Frédéric Limosin, Jean-Yves Loze, Claudette Boni, Louis-Philippe Fedeli, Michel Hamon, Frédéric Rouillon, Jean Adès, Philip Gorwoo. The A9 allele of the dopamine transporter gene increases the risk of visual hallucinations during alcohol withdrawal in alcohol-dependent women. Neuroscience letters. vol 362. issue 2. 2004-07-23. PMID:15193761. |
previous studies have found an association between the a9 allele (nine-copy repeat) of the dopamine transporter (dat) gene and two complications of alcohol withdrawal, namely delirium tremens (dt) and alcohol withdrawal seizures (aws). |
2004-07-23 |
2023-08-12 |
Not clear |
| Philip Gorwood, Frédéric Limosin, Philippe Batel, Michel Hamon, Jean Adès, Claudette Bon. The A9 allele of the dopamine transporter gene is associated with delirium tremens and alcohol-withdrawal seizure. Biological psychiatry. vol 53. issue 1. 2003-04-22. PMID:12513948. |
the a9 allele of the dopamine transporter gene is associated with delirium tremens and alcohol-withdrawal seizure. |
2003-04-22 |
2023-08-12 |
Not clear |
| Philip Gorwood, Frédéric Limosin, Philippe Batel, Michel Hamon, Jean Adès, Claudette Bon. The A9 allele of the dopamine transporter gene is associated with delirium tremens and alcohol-withdrawal seizure. Biological psychiatry. vol 53. issue 1. 2003-04-22. PMID:12513948. |
the dopamine transporter (dat) plays a key role in homeostatic regulation of dopaminergic neurotransmission and could thus be involved in the variability of two severe alcohol-withdrawal symptoms, alcohol-withdrawal seizure (aws) and delirium tremens (dt). |
2003-04-22 |
2023-08-12 |
Not clear |
| Barbara R Sommer, Lowell C Wise, Helena C Kraeme. Is dopamine administration possibly a risk factor for delirium? Critical care medicine. vol 30. issue 7. 2002-09-17. PMID:12130971. |
is dopamine administration possibly a risk factor for delirium? |
2002-09-17 |
2023-08-12 |
Not clear |
| Barbara R Sommer, Lowell C Wise, Helena C Kraeme. Is dopamine administration possibly a risk factor for delirium? Critical care medicine. vol 30. issue 7. 2002-09-17. PMID:12130971. |
we explored the possibility that the administration of intravenous dopamine increases the risk for delirium as manifested by need for haloperidol. |
2002-09-17 |
2023-08-12 |
Not clear |
| Yosuke Uchitom. [Management of psychiatric symptoms in cancer patients]. Gan to kagaku ryoho. Cancer & chemotherapy. vol 29. issue 7. 2002-08-09. PMID:12146016. |
haloperidol, a neuroleptic agent (antipsychotic) that is a potent dopamine blocker, is the drug of choice for the treatment of delirium in persons with cancer because of the low incidence of related cardiovascular and anticholinergic effects. |
2002-08-09 |
2023-08-12 |
Not clear |
| P T Trzepac. Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Seminars in clinical neuropsychiatry. vol 5. issue 2. 2000-07-06. PMID:10837102. |
neurotransmitters most implicated in delirium that could be candidates to mediate the characteristic symptoms of delirium, as well as the electroencephalogram changes, are acetylcholine and dopamine. |
2000-07-06 |
2023-08-12 |
Not clear |
| P T Trzepac. Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Seminars in clinical neuropsychiatry. vol 5. issue 2. 2000-07-06. PMID:10837102. |
electroconvulsive therapy is described as a special situation in which excess dopamine and delirium may have a therapeutic effect on depression recovery, in contrast with the usual association of delirium with negative effects. |
2000-07-06 |
2023-08-12 |
Not clear |
| P Franke, S G Schwab, M Knapp, M Gänsicke, C Delmo, P Zill, M Trixler, D Lichtermann, J Hallmayer, D B Wildenauer, W Maie. DAT1 gene polymorphism in alcoholism: a family-based association study. Biological psychiatry. vol 45. issue 5. 1999-08-10. PMID:10088054. |
the present study tests the hypothesis that the 9-repeat allele of the dopamine transporter gene (dat1; slc6a3) is more frequent in alcohol-dependent probands--and in particular those with severe withdrawal symptoms (seizures and/or delirium)--compared to nonalcoholics. |
1999-08-10 |
2023-08-12 |
Not clear |
| J M Flacker, L A Lipsit. Neural mechanisms of delirium: current hypotheses and evolving concepts. The journals of gerontology. Series A, Biological sciences and medical sciences. vol 54. issue 6. 1999-07-27. PMID:10411009. |
other neurotransmitters such as dopamine and gamma-aminobutyric acid each may be involved in the development of delirium under special conditions. |
1999-07-27 |
2023-08-12 |
Not clear |
| R C van der Mas. Pathophysiology of delirium. Journal of geriatric psychiatry and neurology. vol 11. issue 3. 1999-03-22. PMID:9894732. |
reduced cholinergic function, excess release of dopamine, norepinephrine, and glutamate, and both decreased and increased serotonergic and gamma-aminobutyric acid activity may underlie the different symptoms and clinical presentations of delirium. |
1999-03-22 |
2023-08-12 |
Not clear |
| K Nakamura, M Kurasawa, Y Tanak. Apomorphine-induced hypoattention in rats and reversal of the choice performance impairment by aniracetam. European journal of pharmacology. vol 342. issue 2-3. 1998-06-08. PMID:9548378. |
we attempted to develop a new delirium model using the direct dopamine agonist, apomorphine, and a choice reaction performance task performed by middle-aged rats. |
1998-06-08 |
2023-08-12 |
rat |
| K Nakamura, M Kurasawa, Y Tanak. Apomorphine-induced hypoattention in rats and reversal of the choice performance impairment by aniracetam. European journal of pharmacology. vol 342. issue 2-3. 1998-06-08. PMID:9548378. |
the present results suggest that apomorphine-induced behavioral disturbances in the choice reaction performance task seems to be a useful delirium model and aniracetam may improve delirium through the action of 2-pyrrolidinone and n-anisoyl-gaba, presumably by facilitating dopamine release in the striatum by acting as an ampa or metabotropic glutamate receptor agonist. |
1998-06-08 |
2023-08-12 |
rat |
| T Sander, H Harms, J Podschus, U Finckh, B Nickel, A Rolfs, H Rommelspacher, L G Schmid. Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biological psychiatry. vol 41. issue 3. 1997-04-29. PMID:9024952. |
allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. |
1997-04-29 |
2023-08-12 |
Not clear |
| H Sano, Y Suzuki, K Ohara, R Yazaki, T Ishigaki, T Yokoyama, K Ohar. Circadian variation in plasma homovanillic acid level during and after alcohol withdrawal in alcoholic patients. Alcoholism, clinical and experimental research. vol 16. issue 6. 1993-01-27. PMID:1335220. |
the higher plasma hva in the dt group indicates that there is some sort of preparatory state whereby dopamine metabolism is involved in the appearance of hallucinations at alcohol withdrawal and can possibly be used as a predictor of otherwise hardly predictable delirium tremens. |
1993-01-27 |
2023-08-11 |
human |
| R G Golodets, N V Govoroi. [Beta-blockers in the complex treatment of alcoholic delirium]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952). vol 83. issue 2. 1983-07-08. PMID:6858485. |
the athena scale, neurovegetative indices as well as those of adrenaline, noradrenaline, dopamine, and dopa excretion were used for delirium gravity estimation. |
1983-07-08 |
2023-08-12 |
Not clear |
| D Athen, H Beckmann, M Ackenheil, E Markiano. [Biochemical studies in delirium tremens (author's transl)]. Arzneimittel-Forschung. vol 28. issue 9. 1979-10-26. PMID:582551. |
during the delirium and a drug-free control period concentrations of 3-methoxy-4-hydroxyphenylglycol (mhpg) and homovanillic acid (hva) in csf, activity of dopamine-beta-hydroxylase (dbh), and urinary excretion of norepinephrine, epinephrine, and dopamine (da) were measured in eight male patients. |
1979-10-26 |
2023-08-11 |
Not clear |
| D Athen, H Beckmann, M Ackenheil, M Markiano. Biochemical investigations into the alcoholic delirium: alterations of biogenic amines. Archiv fur Psychiatrie und Nervenkrankheiten. vol 224. issue 2. 1977-12-29. PMID:921518. |
in eight male patients with alcoholic delirium concentrations of 3-methoxy-4-hydroxyphenylglycol (mhpg) and homovannilic acid (hva) in csf, activity of dopamine-beta-hydroxylase (dbh) and urinary excretion of noradrenaline (na), adrenaline (a), and dopamine (da) were measured during the delirium and a drug-free control period. |
1977-12-29 |
2023-08-11 |
Not clear |